Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
Cohort Study of Patients With Primary Hepatocellular Carcinoma or Cholangiocarcinoma
The main objective is to describe the evolution of patients treated for a primary malignant hepatobiliary tumor (hepatocellular carcinoma or cholangiocarcinoma) over the long course.
The collection of data from patients with CHC and cholangiocarcinomas who are cancers with poor prognosis is a major challenge to improve patients'care (diagnosis, prognosis); facilitate the search for new therapeutic targets and the follow-up of clinical studies; and develop personalized treatments.
Study Arms / Comparison Groups
patients with Hepatocellular carcinoma
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Primary Completion Date
Inclusion Criteria: Inclusion Criteria : - Age ≥ 18 years olds - Medical care in Nephrology department since 2015 Cholangiocarcinoma: - Histologically and cytologically documented cholangiocarcinoma, regardless of the stage of the disease Hepatocellular carcinoma: - Hepatocellular carcinoma at any stage of the disease, presenting the diagnostic criteria according to the diagnostic criteria of Barcelona : Tumor of more than 1 cm, developed on cirrhosis liver with arterial phase hyperenhancement and washout in the portal venous or delayed phases on CT and MRI - Hepatocellular histologically documented Exclusion Criteria: - Lack of patient non-opposition
18 Years - N/A
Marie LEQUOY, MD, +330149283154, [email protected]
Assistance Publique - Hôpitaux de Paris
Marie LEQUOY, MD, Principal Investigator, AssistancePublique-Hôpitaux de Paris